ES2046189T3 - Derivados de dihidropiridina y composiciones de los mismos. - Google Patents
Derivados de dihidropiridina y composiciones de los mismos.Info
- Publication number
- ES2046189T3 ES2046189T3 ES198787112302T ES87112302T ES2046189T3 ES 2046189 T3 ES2046189 T3 ES 2046189T3 ES 198787112302 T ES198787112302 T ES 198787112302T ES 87112302 T ES87112302 T ES 87112302T ES 2046189 T3 ES2046189 T3 ES 2046189T3
- Authority
- ES
- Spain
- Prior art keywords
- derivatives
- dihydropyridine
- compositions
- salts
- acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
EL OBJETO DE LA PRESENTE INVENCION ES PROPORCIONAR DERIVADOS DE DIHIDROPIRIDINA DE SUS SALES DE ADICION DE ACIDOS QUE TIENEN ACTIVIDADES FARMACOLOGICAS AUN MAS EXCELENTES.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61200849 | 1986-08-27 | ||
JP25307786 | 1986-10-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2046189T3 true ES2046189T3 (es) | 1994-02-01 |
Family
ID=26512428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES198787112302T Expired - Lifetime ES2046189T3 (es) | 1986-08-27 | 1987-08-25 | Derivados de dihidropiridina y composiciones de los mismos. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0257616B1 (es) |
JP (1) | JPH0686429B2 (es) |
KR (1) | KR950003923B1 (es) |
DE (1) | DE3782378T2 (es) |
ES (1) | ES2046189T3 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0725750B2 (ja) * | 1987-12-18 | 1995-03-22 | 富士レビオ株式会社 | 1,4‐ジヒドロピリジン誘導体 |
ES2143453T3 (es) * | 1988-05-19 | 2000-05-16 | Yoshitomi Pharmaceutical | Uso de derivados de dihidropiridina para la profilaxis o el tratamiento de trastornos de la circulacion cerebral. |
US5286869A (en) * | 1988-12-15 | 1994-02-15 | Fujirebio Kabushiki Kaisha | 1,4-dihydropyridine derivatives |
JP2838282B2 (ja) * | 1988-12-29 | 1998-12-16 | 吉富製薬株式会社 | 血管攣縮治療剤 |
JPH03141257A (ja) * | 1989-10-26 | 1991-06-17 | Green Cross Corp:The | ジヒドロピリジン誘導体 |
CA2038744C (en) * | 1990-03-23 | 2002-01-08 | Yoshitomi Pharmaceutical Industries Ltd. | Pharmaceutical composition containing slightly water-soluble drug |
DE69132927T2 (de) * | 1990-06-25 | 2002-10-02 | Mitsubishi Pharma Corp | Verwendung von Dihydropyridinen in kardiotonischen pharmazeutischen Zusammensetzungen |
CA2138297A1 (en) * | 1993-04-19 | 1994-10-27 | Yoshitomi Pharmaceutical Industries Ltd. | Novel pharmaceutical use of dihydropyridine derivative |
CA2147762A1 (en) * | 1993-08-25 | 1995-03-02 | Hiroshi Shinyama | Circulatory disorder improving agent |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2935451A1 (de) * | 1979-09-01 | 1981-03-19 | Bayer Ag, 5090 Leverkusen | Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel |
WO1983003249A1 (en) * | 1982-03-17 | 1983-09-29 | Yoshitomi Pharmaceutical | 1,4-dihydropyridine-3,5-dicarboxylate derivatives |
DE3377352D1 (en) * | 1982-06-03 | 1988-08-18 | Pierrel Spa | Dihydropyridines with an antagonistic activity to calcium, process for their preparation, and pharmaceutical compositions containing them |
IL77843A (en) * | 1985-02-11 | 1989-07-31 | Syntex Inc | Dihydropyridine derivatives,process and novel intermediates for their preparation and pharmaceutical compositions containing them |
-
1987
- 1987-08-21 JP JP62209025A patent/JPH0686429B2/ja not_active Expired - Lifetime
- 1987-08-25 DE DE8787112302T patent/DE3782378T2/de not_active Expired - Fee Related
- 1987-08-25 ES ES198787112302T patent/ES2046189T3/es not_active Expired - Lifetime
- 1987-08-25 EP EP87112302A patent/EP0257616B1/en not_active Expired - Lifetime
- 1987-08-27 KR KR1019870009355A patent/KR950003923B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR950003923B1 (ko) | 1995-04-20 |
DE3782378D1 (de) | 1992-12-03 |
KR880002828A (ko) | 1988-05-11 |
JPS63225356A (ja) | 1988-09-20 |
EP0257616A3 (en) | 1989-01-11 |
EP0257616B1 (en) | 1992-10-28 |
DE3782378T2 (de) | 1993-03-11 |
EP0257616A2 (en) | 1988-03-02 |
JPH0686429B2 (ja) | 1994-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2054860T3 (es) | Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos. | |
ES2110003T3 (es) | Nuevas composiciones a base de derivados de la clase de los taxanos. | |
MX9203380A (es) | Derivados de carbazolil-(4)-oxi-propanolamina y composiciones farmaceuticas que los contienen. | |
ES2071621T3 (es) | Enantiomero dextrogiro del alfa-(tetrahidro-4,5,6,7-tieno-(3,2-c)-piridil-5)(cloro-2-fenil) acetato de metilo, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen. | |
MX9306986A (es) | Composiciones farmaceuticas a base de taxoides. | |
ES2058185T3 (es) | Derivados de camptotecina y procedimiento para su preparacion. | |
ES2085876T3 (es) | Derivado de bifenilmetano, su utilizacion y composiciones farmacologicas que contienen el mismo. | |
NO914092D0 (no) | Fremgangsmaate for fremstilling av mercaptoacetylamidderivater | |
AR220522A1 (es) | Nuevos derivados de 1-cianoriletilimidazol y composiciones que los incluyen | |
ES2100314T3 (es) | Derivados de la pirimidina, su procedimiento de preparacion, productos intermedios obtenidos, su aplicacion como medicamentos y composiciones farmaceuticas que las contienen. | |
ES2029842T3 (es) | Procedimiento para preparar un derivado de quinolina. | |
ES2046189T3 (es) | Derivados de dihidropiridina y composiciones de los mismos. | |
MX168030B (es) | Procedimiento para la preparacion de derivados de alcano y alcoxialcano | |
ES2056153T3 (es) | Expectorante que comprende un derivado hidroxialquilcisteina. | |
ES2054650T3 (es) | Fenilacetonitrilos basicamente substituidos, su obtencion y medicamentos que los contienen. | |
NO892338D0 (no) | Middel for insekt- og middbekjempelse. | |
ES2073393T3 (es) | Derivados de acidos 2,4- y 2,5-dicarboxilicos, procedimiento para su preparacion, utilizacion de los mismos asi como medicamentos a base de estos compuestos. | |
ES2183492T3 (es) | Nuevos derivados de nitrono,su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
ES2172023T3 (es) | Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
ES2122221T3 (es) | Compuestos terapeuticos adecuados para el tratamiento de enfermedades conectadas con la deficiencia de glutation, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
ES2182090T3 (es) | Nuevos derivados de pirrol. | |
ES2062997T3 (es) | Vinilcefalosporinas sustituidas, procedimiento para su fabricacion y su uso como medicamento. | |
FR2428045A1 (fr) | Derives silyles de naphtacenones utilisables notamment dans la synthese d'agents antitumeurs | |
ES2038776T3 (es) | Procedimiento de preparacion de derivados de la oxima del 1,2,5,6-tetrahidropiridin-3-carboxaldehido. | |
ES2178718T3 (es) | Nuevos derivados de pirazoles acidos, su procedimiento de preparaacion, su aplicacion como medicamentos, su nueva utilizacion y composicion farmaceuticas que los contienen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 257616 Country of ref document: ES |